At IMBdx, our people are our most valuable asset. We are a team with expertise in NGS laboratory experiments
and clinical NGS data analysis.
We have different cultural and educational backgrounds, but our goal is the same:
Changing the way cancer is diagnosed, treated, and viewed.

• 

  Tae-You Kim MD/PhD

  Co-Founder & CEO

  • Medical oncologist at Seoul National Univ. Hospital
  • Chairman, Korean Cancer Asso.
  • Former Director of Seoul National University Cancer Hospital/Precision Medicine Center
  • Post-doc at William Kaelin Lab, Harvard Univ.

• 

  Duhee Bang PhD

  Co-Founder & Chief Scientific Advisor

  • Professor of Chemistry, Yonsei Univ.
  • Damon Runyon Foundation Fellow, George Church Lab, Harvard Univ.
  • PhD in Chemistry, Univ. of Chicago

• 

  Peter Moon MBA

  Co-Founder & Vice President

  • MBA, University of Dublin
  • Prev. senior roles at SK Innovation and Hyosung Industries

• 

  Hwang-Phill Kim PhD

  Chief Business Officer

  • Former Assoc. Prof., Dept. of Molecular Medicine, SNU
  • Former Asst. Prof., SNU Cancer Research Institute
  • PhD in Tumor Biology, SNU

• 

  Sang-Hyun Song PhD

  Chief Technology Officer

  • Prev. Prof., Dept. of Molecular Medicine, SNU
  • Prev. Asst. Prof., SNU Cancer Research Institute
  • Post-doc at Dr. Dean Lab. (NIH/NIDDK)
  • PhD in Tumor Biology, SNU

• 

  Jinwon Joo CFA/FRM/CAIA/USCPA

  Chief Financial Officer

  • MBA, KAIST College of Business
  • MS in Finance, University of Rochester
  • Prev) AP Investment & Finance Inc./HDC/Samil PwC

• 

  Yongjun Cha MD

  Chief Medical Officer

  • Prev. Staff Physician/Medical Oncologist, National Cancer Center Korea
  • MD, Seoul National University College of Medicine
  • Visiting scholar, Univ of Chicago

• 

  Shiyun Kim

  Planning Director

  • Prev. POSCO HOLDINGS, NEXEN
  • Yonsei Univ. Business Administration

• 

  Meiling Piao

  Global Business development Director

  • Prev. CbsBioscience
  • MSc in Food Science & Nutrition. Heriot-Watt University